Literature DB >> 6651276

Stability of gentamicin, tobramycin, and amikacin in combination with four beta-lactam antibiotics.

R H Glew, R A Pavuk.   

Abstract

The stability of the aminoglycosides gentamicin, tobramycin, and amikacin stored in combination with carbenicillin, piperacillin, cefotaxime, and moxalactam was evaluated at four temperatures (25, 4, -8, and -70 degrees C) over a 3-week period. Amikacin was the most stable of the aminoglycosides and demonstrated no loss of activity when stored with either carbenicillin or piperacillin. Gentamicin and tobramycin were inactivated by carbenicillin and piperacillin at 25 and 4 degrees C, with aminoglycoside activity declining substantially after 8 to 48 h of storage; virtually no loss of gentamicin or tobramycin activity occurred with storage at -8 or -70 degrees C. Cefotaxime and moxalactam produced no degradation of any of the three aminoglycosides.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6651276      PMCID: PMC185358          DOI: 10.1128/AAC.24.4.474

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Interactions of carbenicillin and ticarcillin with gentamicin.

Authors:  M Davies; J R Morgan; C Anand
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

2.  Inactivation of gentamicin by penicillins in patients with renal failure.

Authors:  F R Ervin; W E Bullock; C E Nuttall
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

3.  Structure-activity relationships among the aminoglycoside antibiotics: role of hydroxyl and amino groups.

Authors:  R Benveniste; J Davies
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191

4.  Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin.

Authors:  J E McLaughlin; D S Reeves
Journal:  Lancet       Date:  1971-02-06       Impact factor: 79.321

5.  Therapeutic implications of interaction of gentamicin and penicillins.

Authors:  P Noone; J R Pattison
Journal:  Lancet       Date:  1971-09-11       Impact factor: 79.321

6.  Laboratory and clinical conditions for gentamicin inactivation by carbenicillin.

Authors:  L J Riff; G G Jackson
Journal:  Arch Intern Med       Date:  1972-12

7.  Biological aspects of the interaction between gentamicin and carbenicillin.

Authors:  J A Waitz; C G Drube; E L Moss; E M Oden; J V Bailey
Journal:  J Antibiot (Tokyo)       Date:  1972-04       Impact factor: 2.649

8.  Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside.

Authors:  G W White; J B Malow; V M Zimelis; H Pahlavanzadeh; A P Panwalker; G G Jackson
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

9.  Significance of antimicrobial synergism for the outcome of gram negative sepsis.

Authors:  J Klastersky; F Meunier-Carpentier; J M Prevost
Journal:  Am J Med Sci       Date:  1977 Mar-Apr       Impact factor: 2.378

Review 10.  Gentamicin in 1978.

Authors:  G B Appel; H C Neu
Journal:  Ann Intern Med       Date:  1978-10       Impact factor: 25.391

View more
  6 in total

1.  In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.

Authors:  M D Lyon; K R Smith; M S Saag; G A Cloud; C G Cobbs
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

2.  Microanalysis of beta-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates.

Authors:  Maurice J Ahsman; Enno D Wildschut; Dick Tibboel; Ron A Mathot
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

3.  Comparative inactivation of isepamicin, amikacin, and gentamicin by nine beta-lactams and two beta-lactamase inhibitors, cilastatin and heparin.

Authors:  J N Walterspiel; S Feldman; R Van; W R Ravis
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

4.  In vitro interaction of aminoglycosides with beta-lactam penicillins.

Authors:  S M Wallace; L Y Chan
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

5.  An in vivo assessment of the tobramycin/ticarcillin interaction in cystic fibrosis patients.

Authors:  G W Roberts; R L Nation; A O Jarvinen; A J Martin
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335

6.  Zosyn (piperacillin/tazobactam) reformulation: Expanded compatibility and coadministration with lactated Ringer's solutions and selected aminoglycosides.

Authors:  Narendra R Desai; Syed M Shah; Jonathan Cohen; Matthew McLaughlin; Hema R Dalal
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.